USPTO serial 79400856
Reviewed by CopyMark Law Group
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
KAREN KREIDER GAUNT
KAREN KREIDER GAUNT DINSMORE & SHOHL LLP255 E. FIFTH STREET, SUITE 1900CINCINNATI, OH 45202UNITED STATES| Class | Description | Status | First use |
|---|---|---|---|
| 003 | Cosmetics; body cleaning and beauty care preparations, namely, body wash, body cream, non-medicated body soap, skin creams, skin lotions, skin moisturizers, and nonmedicated skin cleansing preparations; oral hygiene preparations, namely, non-medicated dental sprays; non-medicated skin care preparations; cosmetic preparations, non-medicated creams and lotions for skin care; non-medicated mouthwashes; mouth sprays being non-medicated mouth rinses, non-medicated mouth washes and non-medicated anti-cavity mouth rinses; non-medicated skin care preparations in the form of creams and gels; non-medicated skin care creams and gels for pets and animals | ACTIVE | — |
| 005 | Pharmaceuticals and preparations for medical use, namely, pharmaceutical and medical preparations for the prevention of infections and bacteria-based diseases or disorders; hygienic preparations for medical use, namely, disinfectants for hygienic purposes and oral hygiene preparations for medical purposes in the nature of medicated oral care gels; anti-viral agents, namely, anti-viral disinfectants; anti-bacterial preparations, namely, antibacterial spray, antibacterial pharmaceuticals in the nature of antibiotics, antivirals and antifungals, and antibacterial cleansing and sterilizing preparations for medical use; nasal sprays for medical purposes; decongestant nasal sprays; throat sprays for medical purposes; medicated mouth care preparations; mouthwashes for medical purposes; medicated mouth spray; none of the aforesaid being or consisting of medicinal or medicated supplements or vitamins for use or ingestion by humans; creams and gels for dermatological use; creams and gels for dermatological use, for pets and animals; creams and gels for dermatological use, for veterinary purposes; medicated skin care preparations, creams and lotions for medical use; sanitary preparations for medical use and sanitary articles, namely, sanitary pads, sanitary towels, sanitary napkins, cloths impregnated with sanitary preparations for medical use, and sanitary cleansing solutions; disinfectants and antiseptics; dietary supplements and dietetic preparations for medical purposes; enzyme dietary supplements; enzymes and enzyme preparations for medical purposes not being or consisting of medicinal or medicated supplements or vitamins for ingestion by humans; enzymes and enzyme preparations for veterinary purposes | ACTIVE | — |
| 010 | Medical apparatus and instruments, namely, medical surgical apparatus and instruments for dental use, for use in operating rooms and surgical theatres in hospitals, physician's offices, and medical facilities, and medical apparatus and instruments for surgical procedures utilizing anti-bacterial and anti-viral preparations, and medical apparatus and instruments for use in mouth care and dental care; medical technical apparatus and instruments, for use in mouth care and dental care, namely, surgical apparatus and instruments for dental use | ACTIVE | — |
| 042 | Science and technology services, namely, scientific laboratory testing of materials, and chemical analysis services in the fields of pharmaceuticals and sanitary preparations, scientific research and scientific laboratory testing and analysis services in the fields of pharmaceuticals and sanitary preparations, and research and design in the field of medical technologies for application of pharmaceuticals and sanitary, anti-bacterial, anti-viral, and disinfectant preparations to medical procedures; medical and pharmacological research services; research related to medicine and pharmaceuticals; research related to life science; consultancy relating to research and development in the field of therapeutics; veterinary research | ACTIVE | — |
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 14, 2026 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Sep 11, 2026 | OPPF | OPPOSITION PAPERS RECEIVED AT TTAB | — |
| Sep 11, 2026 | OPNS | OPPOSITION NOTICE (IB REFUSAL) SENT TO IB | — |
| Sep 11, 2026 | OPNC | OPPOSITION NOTICE (IB REFUSAL) CREATED | — |
| Aug 11, 2026 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Aug 11, 2026 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Aug 6, 2026 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Aug 5, 2026 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jul 22, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jul 22, 2026 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Jul 11, 2026 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 11, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 11, 2026 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 11, 2026 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 11, 2026 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Jul 1, 2026 | ZZZX | PREVIOUS ALLOWANCE COUNT WITHDRAWN | — |
| Jun 16, 2026 | PBCR | WITHDRAWN FROM PUB - OG REVIEW QUERY | — |
| May 29, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 27, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 27, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 27, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jan 29, 2026 | RFNP | REFUSAL PROCESSED BY IB | — |
| Jan 8, 2026 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jan 5, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 5, 2026 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jan 5, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 24, 2025 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Dec 24, 2025 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Dec 10, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Dec 10, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Dec 10, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 23, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 23, 2025 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 2, 2025 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Jul 2, 2025 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 2, 2025 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Mar 20, 2025 | LIME | LIMITATION FROM THE IB - REQUEST EXAM REVIEW | — |
| Feb 9, 2025 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jan 21, 2025 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jan 21, 2025 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Dec 27, 2024 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Dec 24, 2024 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Dec 23, 2024 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Dec 18, 2024 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 20, 2024 | LIMG | LIMITATION OF GOODS RECEIVED FROM IB | — |
| Jul 29, 2024 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 29, 2024 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 25, 2024 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |